Anti-Ras antibody
5
(7 Reviews)
|
(50 Publications)
Rabbit Polyclonal RASK antibody. Suitable for IP, WB, IHC-P, ICC/IF and reacts with Mouse, Rat, Human samples. Cited in 50 publications. Immunogen corresponding to Recombinant Fragment Protein within Human KRAS aa 1-200.
View Alternative Names
KRAS2, RASK2, KRAS, GTPase KRas, K-Ras 2, Ki-Ras, c-K-ras, c-Ki-ras
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Ras antibody (AB180772)
Immunofluorescence staining of C6 cells stained for RAS with ab180772 at 1/100 dilution. Nuclei are labeled with DAPI (Blue).
- WB
Supplier Data
Western blot - Anti-Ras antibody (AB180772)
Blocking buffer : 3% nonfat dry milk in TBST.
All lanes:
Western blot - Anti-Ras antibody (ab180772) at 1/1000 dilution
Lane 1:
A-549 cell extract at 25 µg
Lane 2:
HeLa cell extract at 25 µg
Lane 3:
Raji cell extract at 25 µg
Lane 4:
Mouse spleen tissue extract at 25 µg
Lane 5:
Mouse lung tissue extract at 25 µg
Lane 6:
Rat brain tissue extract at 25 µg
Secondary
All lanes:
HRP Goat Anti-Rabbit IgG
Predicted band size: 21 kDa
true
Exposure time: 90s
- WB
CiteAb
Western blot - Anti-Ras antibody (AB180772)
Ras western blot using anti-Ras antibody ab180772. Publication image and figure legend from Wu, Y. H., Huang, Y. F., et al., 2020, Front Pharmacol, PubMed 32194423.
ab180772 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab180772 please see the product overview.
AZD8835 downregulates BRCA1/BRCA2 mRNA expression in KRAS-mutated OVCAR-8 cell via ERK signaling. (A) The mRNA expression levels of BRCA1 and BRCA2 in OVCAR-8 cells treated with different concentrations of AZD compounds for 24 h were evaluated by real-time RT-PCR. All experiments were performed in triplicate. (B) Protein expression levels of p-Akt (S473), p-Akt (T308), Akt, KRAS, p-C-Raf, ERK, and p-ERK in OVCAR-8 cells treated with different concentrations of AZD compounds for 24 h were evaluated by western blot. The β-actin protein was used as an internal loading control. All experiments were performed in triplicate. (C) Protein expression levels of p-Akt (S473), p-Akt (T308), Akt, KRAS, p-C-Raf, ERK, and p-ERK in OVCAR-3, OVCAR-4, and OVCAR-8 cells treated with different concentrations of AZD8835 for 24 h were evaluated by western blot. The β-actin protein was used as an internal loading control. All experiments were performed in triplicate. (D) In the presence of KRAS mutation, AZD8835 inhibited BRCA1/2 expression through ERK signaling.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Ras proteins are pivotal in regulating cell proliferation differentiation and survival. They are often part of larger protein complexes that facilitate signal transduction across cell membranes. These proteins function as binary molecular switches toggling between active (GTP-bound) and inactive (GDP-bound) states. Mutations in Ras proteins such as NRAS Q61R can lead the protein to assume permanently active conformations disrupting normal cellular signaling processes and contributing to oncogenesis.
Pathways
Ras proteins play significant roles in the MAPK/ERK and PI3K/AKT signaling pathways. Their activation leads to a cascade of phosphorylation events that ultimately regulate gene expression. Within these pathways Ras proteins interact with various molecules including RAF kinases and the PI3K protein further illustrating their complex roles in signal propagation. These pathways control many cellular processes including growth differentiation and survival illustrating how Ras proteins integrate multiple signals to modulate cellular outcomes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (50)
Recent publications for all applications. Explore the full list and refine your search
Natural products and bioprospecting 14:58 PubMed39495380
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 17:1687-1706 PubMed38504693
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 51: PubMed38131227
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research communications 3:2623-2639 PubMed38051103
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 8: PubMed37937641
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e17120 PubMed37360090
2023
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 38:1968-1979 PubMed37186036
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell discovery 9:20 PubMed36810288
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell research 33:30-45 PubMed36241718
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 21:125 PubMed35681235
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com